The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price increase of 18.33%. However, over the past six months, we’ve seen a weaker performance of 5.45%. The price of CLLS fallen by 12.70% over the last 30 days. And in the last five days, it has surged by 51.06%.
Cellectis ADR’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $3.38 on 05/06/24, and the lowest price during that time was $1.41, recorded on 12/27/24.
52-week price history of CLLS Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Cellectis ADR’s current trading price is -36.98% away from its 52-week high, while its distance from the 52-week low is 51.06%. The stock’s price range over this timeframe has been between $1.41 and $3.38. The shares of the Healthcare sector company recorded a trading volume of approximately 0.83 million for the day, which was comparatively higher than the average daily volume of 88750.0 over the last three months.
The Connection Between Financial Performance and Market Capitalization
Cellectis ADR (CLLS) has experienced a quarterly rise of 12.46% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 153.55M and boasts a workforce of 221 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.0000, with a change in price of +0.0700. Similarly, Cellectis ADR recorded 72,993 in trading volume during the last 100 days, posting a change of +3.40%.
CLLS’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CLLS stands at 0.87. Similarly, the long-term debt-to-equity ratio is also 0.76.
CLLS Stock Stochastic Average
Cellectis ADR’s raw stochastic average for the past 50 days is currently at 87.80%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 87.80%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 61.95% and 57.27%, respectively.
